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The rapid increase in telemedicine visits during COVID-19 
Chelsea Johnson, MD, Children's Mercy Kansas City, kidzmd2@gmail.com 
Kathryn Taff, MBA, MHA, CPXP, Children's Mercy Kansas City, ketaff@cmh.edu  
Brian R. Lee, PhD, Children's Mercy Kansas City, blee@cmh.edu   




Prior to the COVID-19 pandemic, facilitated telemedicine encounters were available at outreach locations; however, our 
tertiary children’s hospital had not invested widely in direct to patient telemedicine. Our daily pediatric subspecialty visits 
dropped from an average of 2066 visits a day prior to COVID-19 in our community to 1000 patients a day during the 
study period. Over the four-week period from April 15 to May 12, 2020, patient and family experience ratings of 
percentage of positive responses (9 or 10) on the provider rating 0-10 scale between telemedicine and in-person visits 
were compared for our pediatric subspecialty clinics using a Pearson’s Chi Squared test, p-value <0.05 determined 
significance. Several process measures were compared using the same method. Total visits conducted via telemedicine 
and survey response rates were calculated with frequencies and percentages. Of the 14,428 subspecialty visits attended, 
10,135 (70.2%) were telemedicine. Developmental and Behavioral Medicine saw the highest proportion of patients 
(99.5%) via telemedicine while Cystic Fibrosis, Dentistry, and Neurosurgery saw no telemedicine patients. Telemedicine 
visits yielded a 6.5% higher survey response rate than in-person visits. Overall rating of 9 or 10 for telemedicine visits 
was 87.9%, compared to 83.9% for in-person visits (p-value = 0.07). All process measures scored higher in telemedicine 
visits. This may reflect telemedicine visits’ ability to improve the efficiency of care delivery: removing the need to travel, 
park, navigate the building, register for the visit, obtain vital signs and wait for the provider. 
 
Keywords 





The public health crisis of COVID-19 caused a large 
decline in outpatient clinic visits starting in early March 
with the highest sustained decrease in outpatient visits for 
pediatric care.1 In response, practices across the country 
increased their use of telemedicine.1 Indeed, April 2020 
saw a 50% increase in telemedicine use nationally.2 As a 
tertiary children’s hospital with over 35 subspecialties, 
telemedicine had not been an option for most of our 
patients with less than 4% of all outpatient visits 
conducted via a telehealth platform. Most subspecialties 
were experiencing a steady growth in facilitated telemedicine 
visits. These were telehealth services at our regional 
outreach centers that were supported by a specially trained 
nurse tele-facilitator. The tele-facilitator ensured 
exceptional communication between the provider off-site 
and patient and family on-site.  They initiated the 
encounter, managed the interface between doctor and 
patient (including the hands-on physical assessment) and 
addressed technical challenges. However, due to social 
distancing requirements and visitor restrictions in the 
hospital and clinic settings, a direct to patient telemedicine 
platform was necessary to fulfill the volume of patient 
visits scheduled during the height of the COVID-19 
pandemic. 
 
This study evaluates the patient experience ratings for 
direct to patient telemedicine pediatric specialty encounters 
in comparison to in-person visits during a four-week 




Setting and Participants 
This tertiary children’s hospital in the center of the United 
States typically has over 200,000 specialty clinic visits per 
year. Each encounter receives a patient experience survey 
after their visit, so long as they do not fall within the 
exclusionary rules. Exclusion rules include patients who 
have received a survey for another encounter from the 
enterprise within the last 14 days, patients who have 
previously requested not to be surveyed or patients who 
are not living with a parent or permanent guardian.   
 
Data Collection 
A nationally validated survey was administered, one for 
telemedicine and the other for in-person visits.3,4 
Telemedicine surveys were administered via two modes: 
email and interactive voice response (IVR), a 
computerized phone call. Some in-person specialty visits 
also utilized text messaging (SMS) as a survey delivery 
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modality in place of IVR. Each family received up to three 
attempts for survey completion. Families first received an 
email, or an IVR if an email address was not logged within 
the electronic medical record immediately upon 
discharging the encounter. If the family did not respond, a 
phone call was queued between 6:00pm-8:00pm two days 
after the encounter. If the family did not respond to the 
first two attempts, one final phone or text outreach was 
made again between 6:00pm-8:00pm the following day. 
Phone calls left a voicemail with callback instructions, so 
patients and families may complete the survey from the 
details left in the voicemail. The text message provided a 
link to an online survey, the same as the email link. The 
survey was available for 14 days and then expired. 
 
Exposure 
Direct to patient telemedicine visits were instituted via the 
Microsoft Teams platform (Version 1.3.00.9271). Patients 
and their caregivers had to be physically located in either 
Kansas or Missouri and the provider was most often 





The primary outcome measure was percent of 9 or 10 
scores (“positive responses”) on the overall rating 
measured by the question, “Using any number from 0 to 
10, where 0 is the worst provider possible and 10 is the 
best provider possible, what number would you use to rate 
this provider?” Percent positive responses for specialty 
telemedicine visits were compared to in-person visits for 
four weeks (April 15 – May 12, 2020).  
 
The secondary outcome measures were top box responses 
(“yes, definitely” on a four-point Likert scale) for six 
measures in two categories: person-centered and process. 
The person-centered category evaluated aspects of the 
relationship with the provider: getting enough information, 
active listening, trust in the provider and knowledge of the 
child’s medical history. The process questions for both 
surveys included timeliness of meeting with the provider 
and if the family knew what to do if they had questions. 
The telemedicine survey also had two questions about ease 
of connecting via the telemedicine platform and if they 
would recommend telemedicine to family and friends. 
Both surveys also included a final qualitative open-ended 
question to gather comments (Box 1). 
Box 1. Survey questions and rating scales 
 
TELEMEDICINE VISIT   IN-PERSON VISIT 
Question Text Response Scale Question Text 
Outcome 
Using any number from 0 to 10, where 0 is the worst 
provider possible and 10 is the best provider 
possible, what number would you use to rate this 
provider? 
0; 1; 2; 3; 4; 5; 6; 7; 8; 9; 10                              
Worst                                        
Best                    Provider Possible                        
Provider Possible 
Using any number from 0 to 10, 
where 0 is the worst provider 
possible and 10 is the best provider 
possible, what number would you 
use to rate this provider? 
Person-Centered 
Did this provider give you enough information 
about your child's health and treatment? 
No; Yes, Somewhat; Yes, Mostly; 
Yes, Definitely 
Did the care providers give you 
enough information about your 
child's health and treatment? 
Did the care provider listen carefully to you? No; Yes, Somewhat; Yes, Mostly; 
Yes, Definitely 
Did the care providers listen 
carefully to you? 
Did you trust the care providers with your child's 
care? 
No; Yes, Somewhat; Yes, Mostly; 
Yes, Definitely 
Did you trust the care providers 
with your child's care? 
Did the care provider seem to know your child’s 
medical history? 
No; Yes, Somewhat; Yes, Mostly; 
Yes, Definitely 
Did the care providers seem to 
know your child's medical history? 
Process 
Were you able to talk to a care provider in a timely 
manner? 
No; Yes, Somewhat; Yes, Mostly; 
Yes, Definitely 
Was your child seen by a care 
provider in a timely manner? 
Did you know what to do if you had more questions 
after your visit? 
No; Yes, Somewhat; Yes, Mostly; 
Yes, Definitely 
Did you know what to do if you had 
questions after your visit? 
Was this method of connecting with a care provider 
easy to use? 
No, Yes somewhat, Yes mostly, 
Yes definitely 
  
How likely would you be to recommend Telehealth 
to your family and friends? 
0; 1; 2; 3; 4; 5; 6; 7; 8; 9; 10                                     
Not at all                                         




What else would you like to say about your 
experience? 
NA What else would you like to say 
about your experience? 
 
The rapid increase in telemedicine visits during COVID-19, Johnson et al. 
Patient Experience Journal, Volume 7, Issue 2 – 2020  74 
Data Analysis 
Data were entered into Microsoft Excel (Version 
16.0.11929.20436). Pearson’s Chi Squared test for 
significance with p-value <0.05 was used to compare the 
percent positive responses for overall rating between 
telemedicine and in-person subspecialty visits from April 
15 to May 12, 2020. The same method was used to 
compare the top box scores for process measures between 
telemedicine and in-person visits. Descriptive statistics 
were used to show percent of visits within a specialty clinic 
type to be delivered via telemedicine and returned surveys. 
 
The Institutional Review Board at Children’s Mercy 




The impact of COVID-19 on attendance of clinic visits is 
displayed in Figure 1. The average daily attendance for 
clinic attendance from March 9-13, 2020 was 2066 patients 
per day. This number dropped precipitously the following 
week, and direct to patient telemedicine visits were 
instituted the week after (blue bars).(Figure 1) When the 
telemedicine patient experience surveys began on April 15, 
2020, telemedicine visits were 62.2% of the daily visit 
volumes.  
 
Over the four-week period from April 15, 2020 to May 12, 
2020, a total of 15,562 visits were attended, 4370 in-person 
and 11,192 (71.9%) via telemedicine.(Table 1) Variability 
existed by specialty for the percentage of patients seen via 
telemedicine. Developmental and Behavioral Medicine saw 
1582 patients via telemedicine (99.5% of all their visits), 
followed by Sleep with 304 telemedicine visits (99.3%) and 
Weight Management with 170 telemedicine visits (98.3%). 
Hematology/Oncology saw the fewest percentage of their 
patients via telemedicine (n=74, 11.5%), followed by 
Ophthalmology (n=66, 25.9%) and Orthopedics (n=369, 
27.8%). Three clinics – Cystic Fibrosis, Dentistry and 
Neurosurgery – saw no telemedicine patients.  
 
Response rates to the patient experience survey after an 
encounter varied by appointment type and specialty (Table 
2). Telemedicine encounter response rates were slightly 
higher than in-person visits. Of the 2,129 telemedicine 
visits sampled during the study timeframe, 628 responded 
for a response rate of 29.2% (23.5% via email and 76.5% 
via IVR). Of the 3,173 families surveyed for in-person 
visits, 603 responded for a response rate of 26.1% (20.7% 
via email, 0.3% via SMS, and 79.0% via IVR). The 
response rates varied among subspecialties with larger 
variability for the in-person visit type (telemedicine 14.3% 
- 43.8%, in-person 0% - 38.4%). 
 
Figure 1 Daily pediatric specialty encounter volumes by visit type 
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The outcome measure of percent positive overall rating 
was not significantly different between the two visit 
modalities. The percent of telemedicine visits with a score 
of 9 or 10 for overall rating of provider was 87.9%, 
compared to 83.9% for in-person visits (p-value = 0.07). 
(Figure 2) The telemedicine top box responses for the 
person-centered measures were all statistically significantly 
higher than in-person visit responses including getting 
enough information (80.6%, 75.7%, p-value < 0.05), active 
listening (86.6%, 79.7%, p-value < 0.05), trust in the 
provider (86.7%, 78.5%, p-value < 0.001) and knowledge 
of the child’s medical history (78.9%, 58.9%, p-value < 
0.0001). The process measures of timeliness of care 
(70.4% telemedicine, 66.2% in-person, p-value = 0.12) was 










 N n (% row total) n (% row total) 
Specialty 15,562 11,192 71.9% 4,370 28.1% 
ADHD 258 247 95.7% 11 4.3% 
Adolescent  132 77 58.3% 55 41.7% 
Allergy 412 362 87.9% 50 12.1% 
Cardiology 576 201 34.9% 375 65.1% 
Child & Family Therapy 37 34 91.9% 3 8.1% 
Cystic Fibrosis 11 0 0.0% 11 100.0% 
Dental 66 0 0.0% 66 100.0% 
Dermatology 491 407 82.9% 84 17.1% 
Developmental & Behavioral 1,590 1,582 99.5% 8 0.5% 
Eating Disorders 301 274 91.0% 27 9.0% 
Endocrine 1,134 1,015 89.5% 119 10.5% 
ENT 711 585 82.3% 126 17.7% 
Genetics 194 171 88.1% 23 11.9% 
GI 997 962 96.5% 35 3.5% 
Gynecology 74 51 68.9% 23 31.1% 
Hearing & Speech 695 574 82.6% 121 17.4% 
Hematology/Oncology 641 74 11.5% 567 88.5% 
Infectious Diseases 110 77 70.0% 33 30.0% 
Nephrology 466 249 53.4% 217 46.6% 
Neonatal Follow-Up 200 189 94.5% 11 5.5% 
Neurology 1,134 1,057 93.2% 77 6.8% 
Neurosurgery 92 0 0.0% 92 100.0% 
Nutrition 80 76 95.0% 4 5.0% 
Ophthalmology 255 66 25.9% 189 74.1% 
Orthopedics 1,326 369 27.8% 957 72.2% 
Pain Management 93 52 55.9% 41 44.1% 
Plastic Surgery 293 205 70.0% 88 30.0% 
PT/OT 1,734 1,066 61.5% 668 38.5% 
Pulmonology 234 217 92.7% 17 7.3% 
Rehabilitation Medicine 153 119 77.8% 34 22.2% 
Rheumatology 247 186 75.3% 61 24.7% 
Sleep 306 304 99.3% 2 0.7% 
Surgery 199 83 41.7% 116 58.3% 
Urology 147 91 61.9% 56 38.1% 
Weight Management 173 170 98.3% 3 1.7% 
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not statistically different, but knowing what to do if they 
had questions (78.6% telemedicine, 73.0% in-person, p-
value <0.05) did score statistically significantly higher for 
telemedicine visits.  
 
The two telemedicine modality questions are reported in 
Figure 3. The top box response for telemedicine visit 
process metrics of ease of use of the telemedicine platform 
was 63.9%. The likelihood to recommend for telemedicine 
was 74.3%. 





Surveys Returned  
In-Person Clinic Visits 
 n Return rate n Return rate 
Subspecialty Care - Total  628 29.20% 603 26.10% 
ADHD  18 26.50% 0 N/A (0)  
Adolescent Specialty  0 N/A (0)  4 15.40% 
Allergy  12 26.10% 8 26.70% 
Cardiology  3 23.10% 68 27.10% 
Child & Family Therapy  3 30.00% 0 0.0% (1)  
Cystic Fibrosis  0 N/A (0)  1 14.30% 
Dental  0 N/A (0)  8 16.30% 
Dermatology  45 30.40% 18 28.60% 
Developmental & Behavioral  117 27.70% 3 16.70% 
Eating Disorders  0 N/A (0)  0 N/A (0)  
Endocrine  50 29.90% 33 24.80% 
ENT  3 23.10% 22 25.60% 
Genetics  6 22.20% 5 26.30% 
GI  73 26.00% 6 22.20% 
Gynecology  2 33.30% 4 23.50% 
Hearing & Speech  40 29.60% 24 20.30% 
Hematology/Oncology  0 N/A (0)  29 27.40% 
Infectious Diseases  1 14.30% 3 17.60% 
Nephrology  6 25.00% 14 20.30% 
Neonatal Follow-Up  11 21.60% 0 0.0% (5)  
Neurology  126 33.20% 7 12.10% 
Neurosurgery  0 N/A (0)  6 22.20% 
Nutrition  7 43.80% 2 25.00% 
Ophthalmology  0 N/A (0)  28 23.50% 
Orthopedics  33 27.50% 157 27.20% 
Pain Management  0 N/A (0)  0 0.0% (1)  
Plastic Surgery  1 25.00% 12 30.00% 
PT/OT  0 N/A (0)  34 25.40% 
Pulmonology  12 26.70% 1 11.10% 
Rehabilitation Medicine  8 27.60% 3 10.70% 
Rheumatology  26 41.90% 11 23.90% 
Sleep  0 N/A (0)  0 N/A (0)  
Surgery  2 40.00% 84 38.40% 
Urology  2 28.60% 6 37.50% 
Weight Management  21 33.30% 2 33.30% 
If no surveys were sent the value is expressed as N/A (0).  If a survey was sent, but none were returned the value is expressed 
as 0% (number of surveys sent). 
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Figure 2. Overall and process measure positive response ratings 
 
 
For each measure, percent positive (score of 9 or 10 for rating of provider or “Yes, definitely” for other process measures) 
shown in blue for telehealth visits and orange for in-person clinic visits. Each measure with a statistically significant higher 































Figure 3. Distribution of ratings for telehealth visit process measures 
 
Figure on left: Raw scores on a 0-10 scale for likelihood of recommending telehealth to friends or family were 
placed into three categories: Promoter (9-10), Neutral (7-8), and Detractor (0-6).  Figure on right: Survey 
responses about ease of using the telehealth platform was scored on a 4-point Likert scale: Yes, definitely; Yes, 
mostly; Yes, somewhat, or No. 
** * 
* *** * 
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Discussion 
 
The direct to patient telemedicine modality for pediatric 
subspecialty visits at a tertiary children’s hospital was well-
received by the population served. The overall rating for 
the telemedicine encounters was higher than the in-person 
visits, although not statistically significant. It would make 
sense that the null hypothesis should not be rejected, as 
the outcome measure was rating of the provider. The 
telemedicine encounters and in-person encounters are 
largely from the same pool of people. For example, the 
same neurologist or endocrinologist could conduct both 
in-person and telemedicine visits. Therefore, it would be 
impressive to see rating of provider differ significantly 
between the two modalities. The higher provider rating for 
the telemedicine visit may be supported by the statistically 
significantly higher person-centered metrics of the 
telemedicine visits.  
 
Our study was comprised of pediatric specialty patients 
seen either by telemedicine or in-person visits and the 
telemedicine cohort rated their experience equal to or 
better than in-person visits. Several recent studies found 
similarly high rates of patient satisfaction with telemedicine 
encounters. A study of telemedicine care by Massachusetts 
General Hospital showed that “nearly all [patients] 
perceived the quality of care or communication to be the 
same or better than at the traditional and familiar office 
visits.”5 When combining the response options of quality 
of care via telehealth, 83% of respondents reported it 
being the same (62%) or higher (21%) than as an in-
person visit.5 Looking at pediatric specific telehealth, 
Atanda et al. found that 90% of pediatric sports medicine 
patients were satisfied with telemedicine care, saved an 
average of $50 per visit and regained over an hour in total 
wait and visit time.6 Our tertiary children’s hospital cares 
for a large encatchment area, mostly rural. A previous 
study by Walsh and Markus found patients who lived 
farther from the medical campus were more likely to 
schedule a telemedicine visit.7 They also found no 
statistically significant difference in any outcome measure 
between telemedicine and in-person visits for their 
population of patients with rare neurological disease, other 
than telemedicine visits were shorter by an average of 3.4 
minutes (p=0.01).7 In the Donelan et al. study, 79% of the 
study participants found it easier to schedule a follow up 
visit via telemedicine at a convenient time compared to an 
in-person clinic visit at Massachusetts General Hospital.5 
Convenience, time savings, financial savings and better 
access to care are likely reasons patients rate telemedicine 
highly. In this study of pediatric specialty visits, the 
modality of patient visit was not the patient or family’s 
choice, rather the provider determined which previously 
scheduled in-person visits could be converted to 
telemedicine, which encounters required maintaining the 
previously scheduled in-person visit, and which visits 
needed to remain in-person but could be postponed to a 
later date to better accommodate the patient, family and 
staff’s safety. 
 
One would think that an in-person encounter would lead 
to a more ‘personal’ experience. However, all the person-
centered measures were statistically significantly higher in 
the telemedicine visit. Even though they were conducted 
through a screen, the telemedicine encounters led to 
perceptions that the provider was more engaged during 
the encounter. The most impressive difference being the 
20% increase in perception that the provider knew the 
patient’s history during telemedicine visits. It is unknown 
whether the provider prepared more for telemedicine 
visits, such as reviewing the chart prior to initiating the 
virtual encounter. Most providers had decreased patient 
visit loads during the study period (Figure 1) which may 
have led to more time to prepare for the visits. The 
providers may have had easier access to the chart during 
the encounter, verbalizing their review of the chart. The 
patients seen via telemedicine may have been patients 
more familiar to the providers, as less first-time 
consultations were conducted via telemedicine due to the 
telemedicine scheduling guidelines for the institution. 
 
Even though the person-centered measures scored higher 
in telemedicine compared to in-person visits, the process 
measures showed recommendation for the modality was 
still only 74.3%, potentially influenced by the telemedicine 
ease of use score at a meek 63.9%. Perception of 
timeliness of the visit was not statistically significantly 
different between telemedicine (70.4%) and in-person 
visits (66.2%) and was the lowest-scored shared process 
measure. While telemedicine removed some of the 
burdens to receiving in-person care, the flow of the new 
modality of telemedicine was still a barrier to the perfect 
patient experience. The quick ramp up (Figure 1) in use of 
direct-to-patient telemedicine may have led to variability in 
quality of care delivery experience. Indeed, the subspecialty 
clinics had variability in their prevalence of telemedicine 
use (Table 1) and their previous experience conducting 
facilitated telehealth visits. Monitoring patient experience 
feedback for telemedicine visits will be imperative as the 
institution continues to refine the delivery mechanics over 
this new modality for providers.  
 
There are limitations to this preliminary data. The data 
only represent a four-week period, and sentiment about 
medical care may be different during a pandemic. This 
data is only from pediatric subspecialty ambulatory visits 
and may not be applicable to adult visits, ancillary services, 
or urgent/emergent visits. The information technology 
support and platform used by this institution may not be 
available in other settings, nor may be the preferred 
platform. While response rates were similar between in-
person and telemedicine in the 20% range, the impact of 
response bias or demographic difference of the two 
populations or respondents versus non-respondents is not 
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known. It is important to recognize that socioeconomic 
differences may also impact certain patient population 




In this pediatric health care entity, families rated direct to 
patient telemedicine visits for pediatric subspecialty visits 
not statistically different than in-person visits during the 
COVID-19 pandemic. Even though they were physically 
distant from their provider, patients and families reported 
better experience across every person-centered process 
measure compared to in-person visits. While the timeliness 
of the visit rating was better with telemedicine, it was not 
statistically significantly different and continues to be one 
of the lowest scoring process measures for the clinic 
specialties. Interestingly, respondents felt the providers 
knew the patient’s history more when the encounter was 
conducted via telemedicine. With the short study duration, 
it is unknown whether these results will be sustained or 
what the standard for clinic visits will be when the clinic 
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